In a co-culture system allowing the synchronized analysis of degranulation of NK cell subsets, we identified HLA-E as a potent inhibitory factor for anti-myeloma reactivity of NK cells expressing the inhibitory NKG2A receptor (Fig. 5). The gene discussed is HLA-E; the disease is plasma cell myeloma.